These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1481226)

  • 21. Effect of long-term therapy with an oral contraceptive on some aspects of hepatic lipid metabolism in vitro.
    Weinstein I; Belitsky R; Seedman S; Friegly MJ; Trasher TN
    Biochem Pharmacol; 1975 Sep; 24(17):1583-8. PubMed ID: 1191317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coagulation and anticoagulation effects of contraceptive steroids.
    Samsioe G
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1523-7. PubMed ID: 8178901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the antifertility drug enovid in five strains of mice, with particular regard to carcinogenesis.
    Heston WE; Vlahakis G; Desmukes B
    J Natl Cancer Inst; 1973 Jul; 51(1):209-24. PubMed ID: 4352748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Norethindrone in serum after use of an oral contraceptive containing norethindrone acetate.
    Sarkar NN; Laumas V; Agarwal N; Hingorani V; Laumas KR
    Acta Obstet Gynecol Scand; 1983; 62(1):71-6. PubMed ID: 6858629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ethynodiol diacetate and combination--type oral contraceptive compounds on carbohydrate metabolism. I. Six month intravenous glucose tolerance study.
    Goldman JA
    Diabetologia; 1975 Feb; 11(1):45-8. PubMed ID: 1140518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Historical survey of modern reversible contraceptive methods].
    Mbabajende V
    Imbonezamuryango; 1986 Apr; (5):14-7. PubMed ID: 12268230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation.
    Jones GE; Wentz AC; Rosenwaks Z; Shoemaker J
    Am J Obstet Gynecol; 1977 Dec; 129(7):760-76. PubMed ID: 343592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of new low-dosage form of norethynodrel-mestranol: clinical evaluation and endometrial biopsy study.
    Flowers Ce J
    JAMA; 1964 Jun; 188(13):1115-20. PubMed ID: 12275481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboembolic disease associated with norethynodrel: report of six cases.
    Schatz IJ; Smith RF; Breneman GM; Bower GC
    JAMA; 1964 May; 188(6):493-5. PubMed ID: 12255392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menstrual impact of contraception.
    Stubblefield PG
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1513-22. PubMed ID: 8178900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of oral contraceptive steroids.
    Orme ML; Back DJ; Breckenridge AM
    Clin Pharmacokinet; 1983; 8(2):95-136. PubMed ID: 6342899
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D; Godsland IF; Wynn V
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional and compositional bone changes of rats fed the oral contraceptive steroids, mestranol and norethynodrel.
    Yang MG; Mickelsen O
    Nutr Rep Int; 1971 Apr; 3(4):247-53. PubMed ID: 12332667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.